- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.

A new genetic test for patients with colorectal cancer, being studied at AdventHealth, can detect if a patient has cancer from a simple blood draw. The groundbreaking test could allow patients to avoid chemotherapy after having surgery to remove a tumor. The test searches for circulating tumor DNA (ctDNA), which is a sequencing technology that can detect very small amounts of tumor DNA in the body’s circulatory system.
“What we knew is that a lot of those patients were cured with surgery alone. We just didn’t have a way to know which ones had microscopic cancer left in the blood, who needed chemo and who did not,” said Dr. Mohamedtaki Tejani, medical oncologist and director of the Gastrointestinal Oncology program at the AdventHealth Cancer Institute and the AdventHealth Research Institute, told the Orlando Sentinel.
Colorectal cancer is the fourth most common cancer diagnosed in the U.S. and the second leading cause of cancer-related deaths. Dr. Tejani is leading the AdventHealth site with two National Cancer Institute clinical trials that aim to harness this sequencing technology to improve patient care. The trial related to Stage 3 colon cancer and the BESPOKE study are currently enrolling participants through a referral process with the AdventHealth Gastrointestinal Oncology Program. Click the link for each study for more information on how to enroll.
In the future, Dr. Tejani hopes this genetic test, which has to be ordered by a physician, can also be used to prescreen for very early-stage colon cancer, and also more effectively treat other cancers, such as gynecologic or pancreatic cancers.
Read the full Orlando Sentinel story here.
Recent News
On the day of his planned wedding, Mike Rounkles suffered a life-threatening heart attack. Thanks to fast action by Johnson County MED-ACT and AdventHealth Shawnee Mission team members, he received...
A teenager with autism met with the Flight 1 team to tour its helicopter and facilities.
What's your personal why behind your job? AdventHealth President/CEO David Banks shares about when it clicked for him early on in his career with the organization.
A first-of-its-kind report from global consulting firm Charles River Associates shows AdventHealth contributed over $16 billion in economic benefits to Florida in 2023.
Instead of relying on doctor's office visits every few weeks, the health system's new program prompts virtual visits for uncontrolled blood pressure.
AdventHealth is the first in Wesley Chapel to offer HYDROS™ Robotic System: A leading-edge AI-powered platform for Aquablation Therapy to treat BPH, or Benign Prostatic Hyperplasia.
The success of this case underscores the impact of early symptom recognition, coordinated EMS response, and hospital readiness.
AdventHealth South Overland Park has earned The Joint Commission’s Gold Seal of Approval® and the American Heart and Stroke Association’s Heart-Check mark for Primary Stroke Certification.
AdventHealth Zephyrhills honors first responders during EMS Week.
Hear from our doctors and nurses why they love our EMS partners, and join us in saying thank you.
Skin Cancer Awareness Month serves as a crucial reminder of the importance of vigilance in detecting and preventing skin cancer, the most common cancer affecting both men and women in the United...
A former patient of AdventHealth Littleton returned to recognize NICU moms on Mother’s Day.